Merck to acquire Prometheus Biosciences for US$10.8bn
MULTINATIONAL pharmaceutical company Merck will buy Prometheus Biosciences for about US$10.8bn, a...
News - Pharma
BioNTech and Matinas collaborate on mRNA vaccines
BIONTECH has signed a collaboration agreement with Matinas BioPharma to advance formulations for ...
Ebola vaccine stockpile established
A STOCKPILE of Ebola vaccine has been established by humanitarian organisations to help better pr...
Attention turns to vaccine production following successful trials
FOLLOWING three highly-encouraging Covid-19 vaccine trials, the light at the end of the tunnel su...
Continuous crystallisation workflow enables high precision manufacturing of pharmaceuticals
A WORKFLOW has been developed that allows for high precision manufacturing of active pharmaceutic...
Takeda mulls bid for Shire
JAPAN’S Takeda Pharmaceutical has revealed it is considering a bid for Ireland’s Shire as it seek...
Monitoring tablet production with near-infrared chemical imaging
A STUDY has shown that near-infrared chemical imaging (NIR CI) can be used for monitoring the mix...
New method weeds out flipping drugs
A NEW method has been developed to help drug developers weed out compounds that could potentially...
Roche buys Ignyta for US$1.7bn
ROCHE has agreed a deal to buy oncology drug company Ignyta for US$27/share, a total of US$1.7bn.
Preventing epidemics before they break out
Coalition seeks sustainable vaccine development
Record UK fine for Pfizer for drug price hike
Distributor Flynn Pharma also fined
UK competition authorities fine GSK 376m
CMA rules GSK kept generic alternatives from market
Recent Editions
Catch up on the latest news, views and jobs from The Chemical Engineer. Below are the four latest issues. View a wider selection of the archive from within the Magazine section of this site.
